Title Credit Start and expiration datessort descending Member price Non-member price
Asthma Medications
1.25 NAPNAP Contact Hour 1.25 Pharmacology Hours With more than 30 respiratory inhalers on the market, how do you choose which is best for your patient? Should you prescribe a metered dose inhaler or a dry power? Or perhaps a nebulized medication? What about your patient with the most difficult to control asthma? Do you start them on biologics? Which one? This session will help you to make these decisions based on the evidence.
  • 1.25 Contact hours
05/05/2017 to 05/31/2019 $12.00 $25.00
Bullying: What the PNP Needs to Know
Despite generations of doubt about the true impact of bullying, it is now clear that childhood bullying can have significant lifelong consequences for victims and bullies alike. Recent school shootings and suicides by students who have been victims of bullying have helped to solidify public awareness of the gravity of the problem of childhood bullying. Adults who were frequently bullied in childhood have an increased frequency of psychiatric disorders, including anxiety, depression, and suicidality, extending into middle age.Bullying is clearly a pediatric health care problem. This continuing education article will explore bullying in terms of definitions, epidemiology, types, risk factors, resilience factors, consequences, and implications for practice. J Pediatr Health Care. (2018)
  • 1.00 Contact hours
06/22/2018 to 06/28/2019 $0.00 $10.00
Newborn Screening for Lysosomal Storage Disorders
1.0 NAPNAP Contact hour, 0.5 Rx hours. Lysosomal storage disorders (LSDs) are a heterogeneous group of approximately 50 rare inheritedmetabolic conditions that result from enzyme deficiencies that interfere with lysosome function. Although often grouped together, there is great variability regarding age of onset, severity, treatment, and outcomes for each disorder and subtype. Currently, laboratory methods are available to test newborns for seven of these conditions. Although newborn screening programs remain state-based, each at a different phase of condition review and implementation, if newborn screening for LSDs has not yet been adopted by the state within which you practice, it likely will. Given the extremely low prevalence and limited provider familiarity with these conditions, this article provides an overview of LSDs and the seven conditions for which newborn screening is available. It offers information about each of the conditions including enzyme deficiency, mode of inheritance, incidence rates, types, clinical course, and available as well as potential treatment options. J Pediatr Health Care. (2018) 32, 285-294.KEY
  • 1.00 Contact hours
04/16/2018 to 06/30/2019 $0.00 $10.00
New Approaches to the Use of Antibiotics
We all recognize the widespread development to antibiotic resistance within our practices; pharma's antibiotic pipeline is dwindling, technology and guidelines are evolving, and duration of therapy is changing. This course will review where we were, discuss where we are now, and (with the help of a cloudy crystal ball), attempt to analyze how we need to proceed in the coming years of increasing antimicrobial resistance. 1.0 NAPNAP Contact Hour, 1.0 Pharmacology Hour
  • 1.00 Contact hours
06/26/2018 to 06/30/2019 $0.00 $0.00
Juvenile Idiopathic Arthritis: A Focus on Pharmacologic Management
1.50 NAPNAP Contact Hour of which 1.50 contain Pharmacology content. Juvenile idiopathic arthritis is a chronic condition that affects many pediatric patients. It is a prevalent disease and has become the most common rheumatologic disease of childhood. The condition encompasses multiple different forms of chronic arthritides classified based on the location and number of joints affected as well as the presence or lack of a number of different inflammatory markers. The exact etiology is unknown but is thought to be multifactorial with genetic, humoral, and environmental factors playing a keyrole. Many pharmacologic agents are available for use in the treatment of juvenile idiopathic arthritis, with management involving the use of symptom-reducing agents and diseasemodifying antirheumatic drugs. Treatment is not without adverse events, with many of the agents require monitoring regimens and patient education. Without treatment, the progression and chronicity of the disease can result in significant morbidity, with the potential for devastating consequences on the child’s quality of life. J Pediatr HealthCare. (2018)
  • 1.50 Contact hours
08/13/2018 to 09/01/2019 $0.00 $10.00
2017 Pediatric Rx, Module 4- GI Drugs

0.5 NAPNAP Contact Hour 0.5 Pharmacology Hours An extensive review will provide an up‐to‐date information on current recommendations for use of GI drugs in the pharmacological management of common GI pathologies in children.

  • 0.50 Contact hours
10/01/2017 to 09/30/2019 $5.00 $10.00
2017 Pediatric RX, Module 5: Nutraceutical and Supplement Use in Children

1.0 NAPNAP Contact Hour 1.0 Pharmacology Hour An extensive review will provide an up-to-date information on integrating the current evidence regarding the use of supplements in children into primary care pediatric practice.

  • 1.00 Contact hours
10/01/2017 to 09/30/2019 $10.00 $20.00
2017 Pediatric RX, Module 1: What's New in Pediatric Pharmacology

1.25 NAPNAP Contact Hour 1.25 Pharmacology Hours Current pediatric prescribing recommendations will be reviewed. An extensive review and update will provide the participant with an improved understanding of therapeutic benefits as well as potential risks of medications prescribed for children, including efficacy, safety and prescribing recommendations. Current MedWatch Safety Alerts issued by the FDA will also be covered.

  • 1.25 Contact hours
10/01/2017 to 09/30/2019 $12.00 $25.00
2017 Pediatric Rx, Module 2- Respiratory Drugs

1.25 NAPNAP Contact Hour 1.25 Pharmacology Hours An extensive review will provide the participant with up-to-date information pharmacological management of common respiratory illnesses in children.

  • 1.25 Contact hours
10/01/2017 to 09/30/2019 $12.00 $25.00
2017 Pediatric Pharmacology Bundle SAVE

Current pediatric prescribing recommendations will be reviewed. An extensive review and update will provide the participant with an improved understanding of therapeutic benefits, as well as potential risks of medications prescribed for children, including efficacy, safety and prescribing recommendations. Drugs abused by adolescents,nutraceuticals used with children, updates on treatment guidelines and changes in drug labeling will be also reviewed.

10/01/2017 to 09/30/2019 $30.00 $75.00
2017 Pediatric Rx, Module 3- Psychotropic Medications

0.75 NAPNAP Contact Hour 0.75 Pharmacology Hour 0.75 Psychopharmacology Hour An extensive review will provide the participant with up-to-date information about commonly used antidepressants and atypical antipsychotics.

  • 0.75 Contact hours
10/01/2017 to 09/30/2019 $5.00 $10.00
Human Trafficking 101

Up to 87 percent of human trafficking victims have encountered a healthcare professional without being identified. Now is your chance to learn about human trafficking, especially related to children, adolescents and teens, so you are ready to help a victim in your practice setting. Don’t be fooled – trafficking happens in every state and every community. Human Trafficking 101, educates participants about this $32 billion criminal industry and its prevalence in all communities and sectors of our society. Participants will also learn how to recognize the signs of human trafficking in child victims and understand situations and challenges that make kids susceptible to trafficking predators. 

  • 1.50 Contact hours
01/01/2018 to 10/01/2019 $0.00 $15.00
Celiac Disease in the Pediatric Population
0.25 NAPNAP Contact hours. Celiac disease is an autoimmune disorder in which the lining of the gastrointestinal tract is damaged by an immunemediated response to gluten proteins (Allen, 2015). It is a polygenetic disease that only appears in genetically susceptible individuals (Newton & Singer, 2012). Celiac disease can present in a spectrum of manifestations, making it difficult to identify and diagnosis. Currently, the only treatment for celiac disease is a strict, gluten-free diet. Further research is warranted in areas of environmental risk factors and treatments (Allen, 2015; Newton & Singer, 2012). J Pediatr Health Care. (2018)
  • 0.25 Contact hours
10/17/2018 to 10/31/2019 $0.00 $10.00
Food Protein-Induced Enterocolitis Syndrome (FPIES)
1.0 NAPNAP contact hour. Food Protein Induced Enterocolitis Syndrome (FPIES) is a rare but potentially life threatening condition. Symptons occur rapidly and can be severe. FPIES is a non-IGE mediated food allergy and it is important for the clinician to know how to diagnose and treat this condition. Given the severity of symptoms and alteraton in the diet, this can greatly affect the quality of life of families. After review of this module, you will know the signs and symptoms of FPIES on families and know the appropriate resources available for review.
  • 1.00 Contact hours
10/17/2018 to 10/31/2019 $10.00 $20.00
Fracture vs. Break: Is There a Difference?
1.0 NAPNAP Contact Hour This session will provide information regarding pediatric fractures and fracture management. Discussion will include describing types of fractures and understanding X-rays with examples. This session is ideal for both acute and primary care practitioners, as it will detail surgical and nonsurgical treatment options and potential complications of fracture management.
  • 1.00 Contact hours
05/01/2018 to 05/31/2020 $10.00 $20.00

Pages